Tags

Type your tag names separated by a space and hit enter

Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Diagn Microbiol Infect Dis. 2011 Sep; 71(1):87-9.DM

Abstract

Among the extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae and Escherichia coli, 3.9% of K. pneumoniae showed nonsusceptibility to imipenem or meropenem; and their mechanism was the combination of ESBL and/or plasmid-mediated AmpC β-lactamase production and porin loss. The presence of bla(CTX-M-14) and loss of OmpK36 were associated with higher carbapenem MICs.

Authors+Show Affiliations

Department of Laboratory Medicine, School of Medicine, The Catholic University of Korea, 505 Banpo-dong, Seocho-ku, Seoul, 137-701, South Korea. yjpk@catholic.ac.krNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

21397426

Citation

Park, Yeon-Joon, et al. "Prevalence and Contributing Factors of Nonsusceptibility to Imipenem or Meropenem in Extended-spectrum Β-lactamase-producing Klebsiella Pneumoniae and Escherichia Coli." Diagnostic Microbiology and Infectious Disease, vol. 71, no. 1, 2011, pp. 87-9.
Park YJ, Yu JK, Park KG, et al. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Diagn Microbiol Infect Dis. 2011;71(1):87-9.
Park, Y. J., Yu, J. K., Park, K. G., Park, Y. G., Lee, S., Kim, S. Y., & Jeong, S. H. (2011). Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Diagnostic Microbiology and Infectious Disease, 71(1), 87-9. https://doi.org/10.1016/j.diagmicrobio.2010.12.012
Park YJ, et al. Prevalence and Contributing Factors of Nonsusceptibility to Imipenem or Meropenem in Extended-spectrum Β-lactamase-producing Klebsiella Pneumoniae and Escherichia Coli. Diagn Microbiol Infect Dis. 2011;71(1):87-9. PubMed PMID: 21397426.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. AU - Park,Yeon-Joon, AU - Yu,Jin Kyung, AU - Park,Kang Gyun, AU - Park,Yong Gyu, AU - Lee,Seongok, AU - Kim,Soo-Young, AU - Jeong,Seok Hoon, Y1 - 2011/03/11/ PY - 2010/08/16/received PY - 2010/11/12/revised PY - 2010/12/16/accepted PY - 2011/3/15/entrez PY - 2011/3/15/pubmed PY - 2011/12/13/medline SP - 87 EP - 9 JF - Diagnostic microbiology and infectious disease JO - Diagn Microbiol Infect Dis VL - 71 IS - 1 N2 - Among the extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae and Escherichia coli, 3.9% of K. pneumoniae showed nonsusceptibility to imipenem or meropenem; and their mechanism was the combination of ESBL and/or plasmid-mediated AmpC β-lactamase production and porin loss. The presence of bla(CTX-M-14) and loss of OmpK36 were associated with higher carbapenem MICs. SN - 1879-0070 UR - https://www.unboundmedicine.com/medline/citation/21397426/Prevalence_and_contributing_factors_of_nonsusceptibility_to_imipenem_or_meropenem_in_extended_spectrum_β_lactamase_producing_Klebsiella_pneumoniae_and_Escherichia_coli_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0732-8893(10)00583-3 DB - PRIME DP - Unbound Medicine ER -